Invention Grant
US09034318B2 Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria
有权
用于治疗同型胱尿蛋白尿的化学修饰的胱硫醚β-合酶
- Patent Title: Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria
- Patent Title (中): 用于治疗同型胱尿蛋白尿的化学修饰的胱硫醚β-合酶
-
Application No.: US13803804Application Date: 2013-03-14
-
Publication No.: US09034318B2Publication Date: 2015-05-19
- Inventor: Jan P Kraus , Tomas Majtan , Erez Bublil
- Applicant: The Regents of the University of Colorado, a body corporate
- Applicant Address: US CO Denver
- Assignee: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
- Current Assignee: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
- Current Assignee Address: US CO Denver
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Main IPC: A61K38/54
- IPC: A61K38/54 ; C12N9/96 ; C12N9/88 ; C07H21/04 ; C07K1/00 ; A61K38/51 ; A61K45/06 ; A61K31/198 ; A61K31/205 ; A61K31/385 ; A61K9/00
Abstract:
The invention provides reagents and methods for enzyme replacement therapy using chemically modified species of human cystathionine β-synthase (CBS) to treat homocystinuria and other related diseases and disorders.
Public/Granted literature
- US20140212403A1 CHEMICALLY MODIFIED CYSTATHIONINE BETA-SYNTHASE ENZYME FOR TREATMENT OF HOMOCYSTINURIA Public/Granted day:2014-07-31
Information query
IPC分类:
